NCT01582971

Brief Summary

The purpose of this project is to test foot reflexology delivered by a friend or family member in the home for women with breast cancer. The primary aims of the proposed study in a sample of women with breast cancer receiving chemotherapy and/or hormonal therapy are to determine the effects of 4 family- or friend-delivered weekly reflexology sessions compared to an attention control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
256

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Apr 2012

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2012

Completed
Same day until next milestone

Study Start

First participant enrolled

April 17, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 23, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

October 2, 2017

Completed
Last Updated

April 18, 2018

Status Verified

March 1, 2018

Enrollment Period

4 years

First QC Date

April 17, 2012

Results QC Date

March 21, 2017

Last Update Submit

March 20, 2018

Conditions

Keywords

Breast CancerReflexologyComplementary

Outcome Measures

Primary Outcomes (4)

  • The M.D. Anderson Symptom Inventory (MDASI)

    The M.D. Anderson Symptom Inventory (MDASI) evaluates severity of 13 symptoms experienced by cancer patients (pain, fatigue, nausea, disturbed sleep, distress, shortness of breath, difficulty remembering, decreased appetite, drowsiness, dry mouth, sadness, vomiting, numbness/tingling) on the scale from 0=symptom not present to 10=as bad as you can imagine. Summed symptom severity score ranging from 0 to 130 was derived. MDASI also assesses how much symptoms interfered with 6 aspects of daily life: general activity, mood, work (including work around the house), relations with other people, walking, and enjoyment of life on the scale from 0=did not interfere to 10=interfered completely. Summed interference score ranging from 0 to 60 was derived. Higher symptom severity and interference scores represent worse outcome.

    Week 5 and week 11

  • Patient Reported Outcomes Measurement Information System (PROMIS) V 1.0

    1. PROMIS-Physical functioning subscale contains four items. Score for each item ranging from 1 to 5, yielding a total score ranges from 4 to 20. Raw score is converted to a T-score using PROMIS scoring rules. The T-scores have mean 50 and standard deviation 10 for the general population. 2. PROMIS-Satisfaction with participation in social roles subscale contains four items. Score for each item ranges from 0 to 4, yielding a total score ranges from 0 to 16. Raw score is converted to a T-score using PROMIS scoring rules. The T-scores have mean 50 and standard deviation 10 for the general population. Higher scores representing better outcomes in each subscale.

    Week 5 and week 11

  • Quality of Life Index (QLI)

    The QLI assesses perceived quality of life including health and functioning domain, psychological/spiritual domain, social and economic domain, and family domain. The QLI consists of two sections: one measures respondent's satisfaction with the various domain of life and the other measures the importance of those domains. The satisfaction scores are centered and weighed by the importance scores to obtain the QLI composite score that ranges from 0 to 30 with higher scores representing better outcomes.

    Week 5 and week 11

  • Use of Unscheduled Health Service

    Measured by Conventional Health Service and Productivity Costs to assess the number of unscheduled times the patient visits an emergency room, urgent care center, and hospitalization.

    Week 11

Study Arms (2)

Intervention

EXPERIMENTAL

Reflexology: 4 weekly foot reflexology sessions delivered by friend/family member

Other: Reflexology

Control

NO INTERVENTION

Standard medical care: no reflexology

Interventions

Friend/family member trained in foot reflexology protocol by certified reflexologist; friend/family member provides 4 weekly sessions to patient

Intervention

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 21
  • Diagnosis of breast cancer, Stage III, IV, or Stage I or II with metastasis or recurrence
  • Able to perform basic ADLs
  • Undergoing chemotherapy and/or hormonal therapy for breast cancer
  • Able to speak and understand English
  • Have access to a telephone
  • Able to hear normal conversation
  • Cognitively oriented to time, place, and person (determined via nurse recruiter)

You may not qualify if:

  • Diagnosis of major mental illness on the medical record and verified by the recruiter
  • Residing in a nursing home
  • Bedridden
  • Currently receiving regular reflexology
  • Diagnosis of symptoms of deep vein thrombosis or painful foot neuropathy, which will require medical approval

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Northwestern

Chicago, Illinois, 49201, United States

Location

Hurley Medical Center

Flint, Michigan, 48503, United States

Location

Lemmon-Holton Cancer Center

Grand Rapids, Michigan, 49503, United States

Location

Breslin Cancer Center

Lansing, Michigan, 48910, United States

Location

Sparrow Cancer Center

Lansing, Michigan, 48912, United States

Location

McLaren Macomb

Mount Clemens, Michigan, 48043, United States

Location

St. Joseph Mercy Oakland Hospital

Pontiac, Michigan, 48241, United States

Location

Beaumont Hospital

Royal Oak, Michigan, 48073, United States

Location

St. Johns Providence

Warren, Michigan, 48093, United States

Location

Related Publications (2)

  • Sikorskii A, Niyogi PG, Victorson D, Tamkus D, Wyatt G. Symptom response analysis of a randomized controlled trial of reflexology for symptom management among women with advanced breast cancer. Support Care Cancer. 2020 Mar;28(3):1395-1404. doi: 10.1007/s00520-019-04959-y. Epub 2019 Jul 2.

  • Luo Z, Wang L, Sikorskii A, Wyatt G. Healthcare service utilization and work-related productivity in reflexology intervention for advanced breast cancer women. Support Care Cancer. 2019 Aug;27(8):2837-2847. doi: 10.1007/s00520-018-4592-4. Epub 2018 Dec 14.

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Musculoskeletal Manipulations

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Results Point of Contact

Title
Dr. Gwen Wyatt
Organization
Michigan State University

Study Officials

  • Gwen Wyatt, PhD, RN

    Michigan State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 17, 2012

First Posted

April 23, 2012

Study Start

April 17, 2012

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

April 18, 2018

Results First Posted

October 2, 2017

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations